2019
$518M
from 12 investors over 12 rounds
Eikon Therapeutics raised $518M on January 6, 2022
Investors: StepStone Group, T. Rowe Price, Lux Capital, Horizons Ventures, Schroders Capital, The Column Group and Innovation Endeavors
Eikon Therapeutics raised $148M on May 5, 2021
Investors: Lux Capital, The Column Group, Innovation Endeavors and Foresite Capital
Eikon Therapeutics raised undisclosed on January 1, 2019
Investors: Lux Capital